{
    "Trade/Device Name(s)": [
        "Premier Hb9210\u2122",
        "Premier Hb9210\u2122 HbA1c Analyzer",
        "Premier - HbA1c",
        "Premier - A1c"
    ],
    "Submitter Information": "Trinity Biotech",
    "510(k) Number": "K112015",
    "Predicate Device Reference 510(k) Number(s)": [
        "K891235"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP"
    ],
    "Summary Letter Date": "October 07, 2011",
    "Summary Letter Received Date": "October 17, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c (HbA1c)"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube",
        "Sodium fluoride tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Premier Hb9210\u2122M system",
        "Trinity Biotech AFFiNITY Software"
    ],
    "Method(s)/Technology(ies)": [
        "High Performance Liquid Chromatography (HPLC)",
        "Boronate affinity chromatography"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "Chromatography"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Trinity Biotech Premier Hb9210\u2122 analyzer for quantitative measurement of HbA1c in whole blood using HPLC boronate affinity chromatography",
    "Indications for Use Summary": "Quantitative measurement of hemoglobin A1c (HbA1c) in human capillary and venous whole blood for monitoring long-term glycemic control in individuals with diabetes mellitus; for in vitro diagnostic use only",
    "fda_folder": "Hematology"
}